Original news and analysis on international IP policy
World Intellectual Property Organization delegates negotiating this week for a possible agreement on protection of traditional knowledge have advanced the text from which they are working, according to a copy obtained by Intellectual Property Watch. Meanwhile, the brand-name pharmaceutical industry sought to explain an alleged biopiracy case at a side event at WIPO today.
The adoption of a Development Agenda by the General Assembly of the World Intellectual Property Organization three years ago was seen by most as a success for developing countries and a sign that the organisation was assuming its role as a United Nations agency to a fuller extent. However, according to a lead official on Development Agenda implementation, there is still a long way to go and changes are needed.
Developing countries are not taking advantage of discoveries made by their scientists and researchers because they lack an appropriate intellectual property infrastructure and expertise, according to a long-time United States proponent of IP rights speaking in Geneva last week. He called for development funds to be redirected to address these shortcomings rather than only supporting IP enforcement initiatives.
Access to essential medicines in least developed countries (LDCs) could be facilitated through local production, according to a report released today by the United Nations Conference on Trade and Development.
NEW YORK – The United States Patent and Trademark Office is operating at a “higher level” these days, trying to look beyond patent numbers to patent quality and value, USPTO Director David Kappos told a group of licensing executives yesterday.
A debate has arisen this week among World Intellectual Property Organization members over a WIPO secretariat report on implementation of the 2007 Development Agenda, which was intended to infuse a stronger development dimension into the UN agency’s activities.
A pledge against the spread of cancer, diabetes, heart disease and other noncommunicable diseases was made last week by health ministers adopting a “Moscow Declaration” to prevent, and treat such illnesses.
A call for proposals was launched today by the World Health Organization expert group in charge of making recommendations on ways to encourage and finance research and development for diseases that mostly affect developing countries.
Non-communicable diseases such as cancer and diabetes now have a global reach, and are the leading cause of death, according to the World Health Organization, which describes them as an “epidemic.” Once considered problems of rich countries, they now hit low- and middle-income populations the worst, says WHO, but preventive actions could be taken. Meanwhile, civil society is warning about the lack of availability of non-communicable diseases medications in developing countries.
Two civil society groups said the recent World Health Organization agreement on influenza pandemic strategy is an improvement on the present situation but has key shortcomings.
Niels Louwaars of the Centre for Genetic Resources, Wageningen University, The Netherlands, discusses the importance of plant breeder’s rights. He makes the case for a carefully balanced protection for plant breeders and changes to patents in agriculture, in order to ensure a competitive, diversified supply of plant varieties and seeds.
Free culture leader and Harvard University law professor Larry Lessig was at the European Organization for Nuclear Research (CERN) yesterday to talk about access to scientific knowledge on internet. In the symbolic place where the World Wide Web was invented and where scientists are now trying to unravel the creation of the universe, Lessig praised CERN’s open access initiative and in this temple of reasoning, said the copyright architecture was on the edge of absurdity.